| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO And President | See Remarks
1 company
Kumar Neil is a Chief Executive Officer at BridgeBio Pharma, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $41.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 120,000 | $32.28 | $3,874,030.43 | -0.7% | |
| Feb 5, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 30,893 | $34.87 | $1,077,390.29 | -1.1% | |
| Feb 4, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sell | 89,107 | $34.70 | $3,091,609.79 | -1.0% | |
| Jan 3, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sell | 120,000 | $32.52 | $3,902,416.96 | -0.7% |